Printer Friendly
The Free Library
14,764,589 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Applied DNA Sciences, Inc. Engages the Investor Relations Group of New York.


Business Editors

LOS ANGELES Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. , Calif.--(BUSINESS WIRE)--Sept. 18, 2003

Applied DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 Sciences, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: APDN) has retained The Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 Group, Inc. (IRG (1) (InterRecord Gap) See interrecord gap.

(2) (Internet Research Group, Los Altos, CA, www.irgintl.com) A research and consulting firm founded in 1993 that specializes in developing business strategies for Internet-related companies.
), based in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
, to serve as its new financial relations and corporate communications company.

The Investor Relations Group will endeavor to develop Applied DNA Sciences' investor base by individually and personally introducing the company and its management to pre-qualified fund managers and other investment professionals. IRG will also provide counsel regarding communication with the investment community, as well as a full complement of public relations public relations, activities and policies used to create public interest in a person, idea, product, institution, or business establishment. By its nature, public relations is devoted to serving particular interests by presenting them to the public in the most  services.

"Now that we have introduced our embedded-DNA security products to the market, it is an opportune time to launch a more affirmative outreach program to raise awareness of our company and the significant opportunities for growth on which we are beginning to capitalize," commented Larry Lee, President and Chief Executive Officer. "IRG's solid history of making introductions and cultivating relationships on behalf of their portfolio companies makes them an ideal partner to help us accomplish these goals."

In the future, all investor and media inquiries relating to Applied DNA Sciences, Inc. should be directed to The Investor Relations Group, 11 Stone Street, 3rd Floor, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10004. Telephone: 212.825.3210. Financial inquiries may also be directed to Mr. Gerhard Wehr, Chief Financial Officer of Applied DNA Sciences, Inc. at 310.860.1362.

About Applied DNA Sciences

Applied DNA Sciences, Inc. provides proprietary, DNA-embedded biotechnology security solutions, using plant DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identify theft and unauthorized intrusion. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. (http://www.biowell.com/tw/eng) of Taiwan. The company develops, markets and sub-licenses DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences' technology addresses the more than $350 billion in counterfeit products sold each year, as well as the multi-billion dollar homeland security market. The company is headquartered at 9255 West Sunset Boulevard, Los Angeles, CA 90069. Tel: 310.860.1362, Fax: 310.860.1303 or visit www.ADNAS.com.

About The Investor Relations Group

The Investor Relations Group, Inc. (IRG), founded in 1996, represents select publicly traded companies publicly traded company

A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market.
 and has a unique specialization for assisting those in the small-cap sector. IRG arranges one-on-one meetings for its portfolio companies with pre-qualified money managers handling investment portfolios that range from $10 million to $10 billion+ selected from its proprietary contact base of over 27,000 pre-qualified fund managers who have a history of investing in small-cap stocks. IRG is a full-service corporate communications company providing press release and shareholder communications writing and serving as the primary contact for the investment community on behalf of its portfolio companies. IRG also houses a full-service public relations arm that specializes in building awareness of its companies within the financial and trade media, as well as the public at large.

The statements made by Applied DNA Sciences, Inc. (The Company) may be forward-looking in nature and are made pursuant to the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Forward-looking statements describe the Company's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Applied DNA Sciences, Inc. Actual results could differ materially from those projected due to changes in interest rates, market competition, changes in the local and national economies, and various other factors. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 18, 2003
Words:616
Previous Article:Net2Printer Provides Simple Local Network Printing from Terminal Services.
Next Article:Symyx Technologies Announces Webcast of Presentation at UBS Global Life Sciences Conference.



Related Articles
Applied Biosystems and Celera Diagnostics to Webcast Investor Meeting.
Applied Biosystems Group and Celera Genomics Group Second Quarter FY 2002 Financial Results Scheduled for Release January 23, 2002.
Applied Biosystems Group and Celera Genomics Group Third Quarter FY 2002 Financial Results and Conference Call Scheduled for Release April 25, 2002.
Applied Biosystems Group and Celera Genomics Group Fourth Quarter and Year-End FY 2002 Financial Results and Conference Call Scheduled for July 25,...
Applied DNA Sciences Approved for S&P Listing; Company Also Engages The Del Mar Consulting Group, Inc.
Applied Biosystems Group and Celera Genomics Group Fourth Quarter and Year-End FY 2003 Financial Results and Conference Call Scheduled for July 23,...
Applied Biosystems to Webcast Presentation and Breakout Session at UBS Global Life Sciences Conference.
Applied DNA Sciences, Inc. Engages Vertical Capital Partners, Inc.
DNA Sciences Inc.(Technology)
Applied DNA Sciences Retains Stern & Co. as Investor and Media Relations Counsel.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles